Arrhythmia
What this study is
The primary objectives for the registry is to evaluate the overall incidence of serious complications or adverse events for primary implants and replacement devices, and assess the cost and time efficiency for both physicians and patients. The Registry is a multi ASC data collection registry. Data collection will occur at the time of screening, implant, and 2 weeks after implant at the time of wound check.
Study details
- Sponsor
- QuesGen Systems Inc
- Conditions
- Arrhythmia
- Enrolling
- 500 people
- Starts
- 2017-08-24
- Est. completion
- 2028-08-24
- Record
- View on ClinicalTrials.gov ↗
Who can join
Sex ALLHealthy volunteers Not acceptedYou may qualify if
- Physician recommendation to receive the implant in an Ambulatory Surgical Center (ASC)
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (1)
1 openCardio Surgical Partners, LLC
Lehi, Utah, United States
- Michael Dutton · Contact801-358-4231mdutton@cardiosp.com
Recruiting
Study team
Sponsor
QuesGen Systems Inc
Study ID 2018-310 Cardiac Registry
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.